1. Home
  2. NEWP vs LYEL Comparison

NEWP vs LYEL Comparison

Compare NEWP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWP
  • LYEL
  • Stock Information
  • Founded
  • NEWP 1972
  • LYEL 2018
  • Country
  • NEWP Canada
  • LYEL United States
  • Employees
  • NEWP N/A
  • LYEL N/A
  • Industry
  • NEWP
  • LYEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEWP
  • LYEL Health Care
  • Exchange
  • NEWP Nasdaq
  • LYEL Nasdaq
  • Market Cap
  • NEWP 259.4M
  • LYEL 207.7M
  • IPO Year
  • NEWP N/A
  • LYEL 2021
  • Fundamental
  • Price
  • NEWP $1.49
  • LYEL $9.51
  • Analyst Decision
  • NEWP
  • LYEL Sell
  • Analyst Count
  • NEWP 0
  • LYEL 2
  • Target Price
  • NEWP N/A
  • LYEL $15.00
  • AVG Volume (30 Days)
  • NEWP 258.3K
  • LYEL 177.3K
  • Earning Date
  • NEWP 05-07-2025
  • LYEL 08-06-2025
  • Dividend Yield
  • NEWP N/A
  • LYEL N/A
  • EPS Growth
  • NEWP N/A
  • LYEL N/A
  • EPS
  • NEWP N/A
  • LYEL N/A
  • Revenue
  • NEWP N/A
  • LYEL $65,000.00
  • Revenue This Year
  • NEWP N/A
  • LYEL N/A
  • Revenue Next Year
  • NEWP N/A
  • LYEL N/A
  • P/E Ratio
  • NEWP N/A
  • LYEL N/A
  • Revenue Growth
  • NEWP N/A
  • LYEL N/A
  • 52 Week Low
  • NEWP $0.93
  • LYEL $7.65
  • 52 Week High
  • NEWP $2.05
  • LYEL $38.40
  • Technical
  • Relative Strength Index (RSI)
  • NEWP 55.11
  • LYEL 49.76
  • Support Level
  • NEWP $1.43
  • LYEL $9.11
  • Resistance Level
  • NEWP $1.58
  • LYEL $9.84
  • Average True Range (ATR)
  • NEWP 0.08
  • LYEL 0.63
  • MACD
  • NEWP 0.01
  • LYEL -0.03
  • Stochastic Oscillator
  • NEWP 68.33
  • LYEL 46.73

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: